These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 31322988)
1. Mental Health Comorbidities and Elevated Risk of Opioid Use in Elderly Breast Cancer Survivors Using Adjuvant Endocrine Treatments. Desai R; Camacho F; Tan X; LeBaron V; Blackhall L; Balkrishnan R J Oncol Pract; 2019 Sep; 15(9):e777-e786. PubMed ID: 31322988 [TBL] [Abstract][Full Text] [Related]
2. Opioid use among female breast cancer patients using different adjuvant endocrine therapy regimens. Tan X; Camacho TF; LeBaron VT; Blackhall LJ; Balkrishnan R Breast Cancer Res Treat; 2017 Sep; 165(2):455-465. PubMed ID: 28639031 [TBL] [Abstract][Full Text] [Related]
3. Impact of patient race and geographical factors on initiation and adherence to adjuvant endocrine therapy in medicare breast cancer survivors. Camacho FT; Tan X; Alcalá HE; Shah S; Anderson RT; Balkrishnan R Medicine (Baltimore); 2017 Jun; 96(24):e7147. PubMed ID: 28614244 [TBL] [Abstract][Full Text] [Related]
4. Racial Differences in Adjuvant Endocrine Therapy Use and Discontinuation in Association with Mortality among Medicare Breast Cancer Patients by Receptor Status. Farias AJ; Du XL Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1266-1275. PubMed ID: 28515111 [No Abstract] [Full Text] [Related]
5. Exploring the role of social support and adjuvant endocrine therapy use among breast cancer survivors. Toledo G; Ochoa CY; Farias AJ Support Care Cancer; 2020 Jan; 28(1):271-278. PubMed ID: 31037379 [TBL] [Abstract][Full Text] [Related]
6. Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system. Kroenke CH; Hershman DL; Gomez SL; Adams SR; Eldridge EH; Kwan ML; Ergas IJ; Kubo A; Kushi LH Breast Cancer Res Treat; 2018 Aug; 170(3):623-631. PubMed ID: 29671113 [TBL] [Abstract][Full Text] [Related]
7. Impact of preexisting mental illness on breast cancer endocrine therapy adherence. Haskins CB; McDowell BD; Carnahan RM; Fiedorowicz JG; Wallace RB; Smith BJ; Chrischilles EA Breast Cancer Res Treat; 2019 Feb; 174(1):197-208. PubMed ID: 30465157 [TBL] [Abstract][Full Text] [Related]
8. Association of Current Opioid Use With Serious Adverse Events Among Older Adult Survivors of Breast Cancer. Winn AN; Check DK; Farkas A; Fergestrom NM; Neuner JM; Roberts AW JAMA Netw Open; 2020 Sep; 3(9):e2016858. PubMed ID: 32930779 [TBL] [Abstract][Full Text] [Related]
9. Association between adjuvant chemotherapy and risk of acute kidney injury in elderly women diagnosed with early-stage breast cancer. Li S; Liu J; Virnig BA; Collins AJ Breast Cancer Res Treat; 2017 Feb; 161(3):515-524. PubMed ID: 27933451 [TBL] [Abstract][Full Text] [Related]
10. Initiation and adherence to adjuvant endocrine therapy among urban, insured American Indian/Alaska Native breast cancer survivors. Emerson MA; Achacoso NS; Benefield HC; Troester MA; Habel LA Cancer; 2021 Jun; 127(11):1847-1856. PubMed ID: 33620753 [TBL] [Abstract][Full Text] [Related]
11. Effects of Previous Medication Regimen Factors and Bipolar and Psychotic Disorders on Breast Cancer Endocrine Therapy Adherence. Haskins CB; Neuner JM; McDowell BD; Carnahan RM; Fiedorowicz JG; Wallace RB; Smith BJ; Chrischilles EA Clin Breast Cancer; 2020 Jun; 20(3):e261-e280. PubMed ID: 32139273 [TBL] [Abstract][Full Text] [Related]
12. Predicting adjuvant endocrine therapy initiation and adherence among older women with early-stage breast cancer. Meneveau MO; Keim-Malpass J; Camacho TF; Anderson RT; Showalter SL Breast Cancer Res Treat; 2020 Dec; 184(3):805-816. PubMed ID: 32920742 [TBL] [Abstract][Full Text] [Related]
13. Association between trajectories of prescription opioid use and risk of opioid use disorder and overdose among US nonmetastatic breast cancer survivors. Chang CY; Jones BL; Hincapie-Castillo JM; Park H; Heldermon CD; Diaby V; Wilson DL; Lo-Ciganic WH Breast Cancer Res Treat; 2024 Apr; 204(3):561-577. PubMed ID: 38191684 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy use among Appalachian breast cancer survivors. Tan X; Marshall VD; Anderson RT; Donohoe J; Camacho F; Balkrishnan R Medicine (Baltimore); 2015 Jul; 94(26):e1071. PubMed ID: 26131828 [TBL] [Abstract][Full Text] [Related]
15. Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence? Ekinci E; Nathoo S; Korattyil T; Vadhariya A; Zaghloul HA; Niravath PA; Abughosh SM; Trivedi MV J Cancer Surviv; 2018 Jun; 12(3):348-356. PubMed ID: 29396760 [TBL] [Abstract][Full Text] [Related]
16. Clinical factors associated with patterns of endocrine therapy adherence in premenopausal breast cancer patients. Woolpert KM; Schmidt JA; Ahern TP; Hjorth CF; Farkas DK; Ejlertsen B; Collin LJ; Lash TL; Cronin-Fenton DP Breast Cancer Res; 2024 Apr; 26(1):59. PubMed ID: 38589932 [TBL] [Abstract][Full Text] [Related]
17. Five-Year Adjuvant Endocrine Therapy Adherence Trajectories Among Women With Breast Cancer: A Nationwide French Study Using Administrative Data. Lailler G; Memoli V; Le Bihan Benjamin C; Ben Diane MK; Lauzier S; Mancini J; Bousquet PJ; Bouhnik AD Clin Breast Cancer; 2021 Aug; 21(4):e415-e426. PubMed ID: 33745868 [TBL] [Abstract][Full Text] [Related]
18. Deconstructing Decisions to Initiate, Maintain, or Discontinue Adjuvant Endocrine Therapy in Breast Cancer Survivors: A Mixed-Methods Study. Bluethmann SM; Murphy CC; Tiro JA; Mollica MA; Vernon SW; Bartholomew LK Oncol Nurs Forum; 2017 May; 44(3):E101-E110. PubMed ID: 28635973 [TBL] [Abstract][Full Text] [Related]
19. Effect of delays in initiation of adjuvant endocrine therapy on survival among women with breast cancer. Lee KT; Jacobs L; Walsh EM; Stearns V; Segal JB Breast Cancer Res Treat; 2020 Dec; 184(3):965-975. PubMed ID: 32914353 [TBL] [Abstract][Full Text] [Related]
20. Opioid Use Disorder and Overdose in Older Adults With Breast, Colorectal, or Prostate Cancer. Roberts AW; Eiffert S; Wulff-Burchfield EM; Dusetzina SB; Check DK J Natl Cancer Inst; 2021 Apr; 113(4):425-433. PubMed ID: 32805032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]